Objective: To investigate whether peri-operative risk stratification of children with ventricular septal defect (VSD) and complete atrioventricular septal defect (CAVSD) complicated with elevated pulmonary vascular resistance could be predicted solely based on measuring systemic oxygen saturation (SaO 2 ) without performing cardiac catheterization. Methods: Records of patients with VSD and CAVSD, who underwent cardiac catheterization from 2002 to 2012 were reviewed and grouped as low (A) and high (B) risk, based on the pulmonary vascular resistance (PVRI) of 6 or >6 Woods units (WU) in room air, respectively. Patients in group B underwent oxygen study to assess pulmonary vascular reactivity. Patients with PVRI 6 6 WU in either room air or on 100% oxygen were deemed operable. Results: Seventy-six patients; (VSD = 45, CAVSD = 31) underwent measurement of pulmonary vascular resistance. All patients with VSD were operated. Forty-two of them had systemic oxygen saturation (SaO 2 ) P 94%. Twenty-four of 31 patients with CAVSD were operated and had * Corresponding author. Addresses: SaO 2 P 83%. SaO 2 of P83% in CAVSD and P94% in VSD had sensitivity and specificity of 95% and 100%, respectively to predict pulmonary vascular resistance based operability. Conclusion: Oxygen saturation on pulse oximetry of P94% in children with VSD and 83% with CAVSD accurately identified operable patients. This criterion may be used as an alternate to invasive assessment of pulmonary vascular resistance. Outcome of operable patients having PVRI > 6 WU in room air is good and similar to those with PVRI < 6 WU.
Introduction
Pulmonary vascular obstructive disease (PVOD) is known to adversely affect the outcome of patients with ventricular septal defect (VSD) and complete atrioventricular septal defect (CAVSD). [1] [2] [3] Those having CAVSD, especially in the presence of Down's syndrome are prone to develop progressive pulmonary vascular obstructive disease (PVOD) even during infancy. 1, 3, 4 Since pulmonary vascular disease progresses over time, early repair of these defects has remarkably improved the outcome by preventing the development of pulmonary vascular disease. 5 However, late referral to tertiary care centers is still a persisting problem in the developing countries. 6, 7 Since January 2002, we adopted a policy of measuring pulmonary vascular resistance by cardiac catheterization for all patients P6 months of age with VSD and CAVSD who had near systemic level pulmonary hypertension by echocardiographic evaluation. Cardiac catheterization was also performed in patients younger than 6 months of age if systemic arterial oxygen saturation (SaO 2 ) was lower than expected (<85% for CAVSD and < 94% for VSD). 8 In this study we aimed to review, if operability in such patients could be established without performing cardiac catheterization and also to evaluate impact of severity of pulmonary vascular obstructive disease on immediate and mid-term postoperative outcome.
Patients and methods

Patient population
The study was done in King Faisal Specialist Hospital and Research Center -Jeddah. The Institutional Review Board approved the present retrospective study. Informed consent for retention and use of patient data for scientific purposes was routinely obtained at the same time of any hospital admission. Eighty-five patients; 47 having VSD and 38 with CAVSD underwent measurement of pulmonary vascular resistance. Mean age and weight for VSD group were 3.5 ± 2.9 years and 11 ± 5.7 kg, respectively and 2.9 ± 3.8 years and 10.5 ± 9.3 kg, respectively for CAVSD. All patients with the diagnosis of VSD and CAVSD having near systemic level pulmonary hypertension on echocardiographic evaluation and who underwent hemodynamic evaluation by cardiac catheterization between 2002 and 2012 constituted the study population. Patients with moderately impaired left ventricular systolic function, severe mitral regurgitation, more than moderate aortic insufficiency, and complete heart block after surgical repair were excluded.
Patients were divided into two groups; group A (low risk) with PVRI < 6 Wood units/m 2 and group B (high risk) with PVRI P 6 Wood units/m 2 in room air. Medical records were reviewed to obtain demographic, echocardiographic and cardiac catheterization, and relevant surgical and postoperative data.
Echocardiogram
Peri-operative studies were reviewed to assess left ventricular systolic function. All patients had an echocardiogram done at least 3 months before the surgical procedure and on the second day postoperatively. Systolic left ventricular function was assessed by visual assessment of two dimensional (2 D) images and graded as mild, moderately, or severely impaired according to the standard practice. 9 In addition to the visual assessment, systolic left ventricular function was assessed by measuring the fractional shortening according to the following formula: Fractional shortening % (FS) = (LVEDD À LVESD)/LVEDD · 100, where LVEDD is the left ventricular end diastolic dimensions, LVESD is the left ventricular end systolic dimensions. Any value below 28% was considered reduced ventricular function. 10 Using echocardiography in two different views (apical four chamber and subxiphoid views) right ventricular volume visually evaluated by at least two different pediatric cardiologists, and tricuspid anulus dimension were measured. Tricuspid anulus dimension of more than 1.0 cm/m 2 SA was considered adequate for biventricular repair. 11 All four cardiac valves were interrogated for stenosis and regurgitation using Doppler imaging. Valvular insufficiency was qualitatively graded as mild, moderate, and severe based on color flow mapping according to the guidelines of American Society of Echocardiography, 10 using para-sternal long and short axes and apical four-chamber views.
Cardiac catheterization
Patients were deemed eligible for catheterization only if they were cleared from any acute illness and chest X-ray showed no parenchymal abnormalities. Studies were performed under Abbreviations used: ASD II, secundum atrial septal defect; CAVSD, common atrio-ventricular septal defect; ICU, intensive care unit; LAP, left atrial pressure; MV, mechanical ventilation; NO, nitric oxide; PAP, mean pulmonary artery pressure; PASP, pulmonary artery systolic pressure; PDA, patent ductus arteriosus; PSPG, peak systolic pressure gradient; PGE, prostaglandin E; PVOD, pulmonary vascular obstructive disease; PVRI, pulmonary vascular resistance; Pump T, pump time; Qp, pulmonary flow; Qs, Systemic flow; RV, right ventricle; SVRI, systemic vascular resistance index; SaO 2 , oxygen saturation; TR, tricuspid regurgitation; VSD, ventricular septal defect; WU, Wood units; X-clamp T, cross clamp time; 2D, two dimensional. conscious sedation using intravenous Midazolam, Ketamine and occasionally Fentanyl. Pulmonary (Qp) and systemic (Qs) blood flows were calculated by applying Fick principal and using assumed oxygen consumption. When pulmonary veins were not directly sampled, pulmonary venous oxygen saturation was assumed to be 98% in room air and equal to that in the aorta or left ventricle in 100% oxygen. Pulmonary vascular reactivity was tested with 100% oxygen inhalation through a non-rebreather face mask for 10 min, if pulmonary vascular resistance index (PVRI) was P6 Wood units in room air. Left atrial pressure was either measured directly or estimated from left ventricular end-diastolic pressure if the left atrium was not accessed. PVRI and systemic vascular resistance (SVRI) were calculated using standard formula and a PVRI of >3 Wood units/m 2 was considered as elevated. 12 Operative and postoperative care Surgical repair was performed under cardiopulmonary bypass and moderate hypothermia (32 C) by two surgeons. Postoperatively, all patients with elevated pulmonary vascular resistance were treated as high risk for the development of pulmonary hypertensive crises. Patients were sedated with Fentanyl and midazolam. Muscular paralysis with non-depolarizing agents was induced in few cases as per discretion of intensive care team. Mild hyperventilation was maintained for at least 24 h. The arterial PH was kept between 7.4 and 7.5. Peripheral arterial line was placed in all patients and systemic pressure was continuously monitored. Pulmonary artery pressure was not recorded as none of the patients had pulmonary artery catheter. Figure 2A Receiver operative characteristic curve for SaO 2 P 94% in VSD group to predict operability. Sensitivity and specificity of SaO 2 P 94% was 95% and 100% respectively.
Figure 2B
Receiver operative characteristic curve for SaO 2 P 83% in CAVSD group to predict operability. Sensitivity and specificity of SaO 2 P 83% was 95% and 100% respectively.
Statistical analysis
Student's t-test was used to compare the hemodynamic data, intraoperative and postoperative variables including pump time, cross clamp time, mechanical ventilation and inotroic support duration, intensive care and hospital stay of the high risk group with the low risk group. Paired t-test was used to compare change in pulmonary flow, systemic flow, pulmonary artery and left atrial pressures, PVRI, Systemic vascular resistance index (SVRI), and PVRI/SVRI ratio with 100% oxygen in high risk groups. Receiver operator curves were generated to estimate sensitivity and specificity of oxygen saturation measured by pulse oximetry to predict operability. The gold standard for the sensitivity and specificity of oxygen saturation was the drop of PVRI after giving 100% oxygen.
Results
Eighty-five patients; 47 having VSD and 38 with CAVSD underwent measurement of pulmonary vascular resistance ( Fig. 1 ) Mean age and weight for the VSD group were 3.5 ± 2.9 years (range 0.5-10 years, median = 3.2 years) and 11 ± 5.7 kg (median = 10.1 kg) respectively and 2.9 ± 3.8 years (0.3-17 years, median = 3.8 years) and 10.5 ± 9.3 kg (median = 12.1 kg) respectively for CAVSD. One patient was <6 months in this series. He had CAVSD and underwent cardiac catheterization because his SaO 2 was 83% on room air. Thirty-five patients (74%) in the VSD group and 17 (44%) in the CAVSD group were older than 1 year. All patients in the VSD group were deemed operable; 23 patients belonged to group A and 24 were in group B. All but three patients in the VSD group had systemic SaO 2 P 94%, their oxygen saturations were 88%, 89%, and 90%. In the CAVSD group 34/38 patients were deemed operable based on PVRI criteria. All patients in CAVSD group, meeting the criteria of operability had SaO 2 P 83%. Of these 15 were in group A and 9 belonged to group B. The four inoperable cases had oxygen saturations of 71%, 75%, 76%, and 80%. Surgery was not performed in another 6 patients for non-medical reasons. Thus 28 patients in this group underwent surgical repair. Medical records of 2 in the VSD group and 4 patients in the CAVSD group were incomplete, leaving 45 patients in VSD and 24 in CAVSD group for outcome analysis. All of these patients had signs and symptoms suggestive of congestive heart failure. Our data showed that in the VSD group, the sensitivity and specificity of Oxygen saturation P94% were 95% and 100% respectively, ( Fig. 2A ). In the CAVSD group sensitivity and specificity of Oxygen saturation P83% were 95% and 100% respectively, (Fig. 2B) .
Echocardiographic data
Preoperative studies showed that right ventricle (RV) was smallish though adequate for biventricular repair in 4/47 patients (8.5%) in VSD and 1/37 (2.5%) in CAVSD group. Left ventricular systolic function was normal in all patients except in one in VSD and two in CAVSD group. Postoperatively, two patients in the CAVSD group had mildly reduced left ventricular systolic function. The remaining patients had normal left ventricular systolic function. In the immediate postoperative period (first day postoperative), 1(2%) in VSD and 3(12%) in CAVSD group had severe tricuspid regurgitation that reduced to moderate degree on follow up. None of the patients in VSD and 1(4%) in CAVSD group developed moderate to severe mitral regurgitation, which persisted on further follow up but without any clinical decompensation. None of the patient had severe pulmonary or more than mild aortic insufficiency.
Cardiac catheterization data
Among the operated patients, the mean pulmonary artery pressure and PVRI in room air were significantly higher in group B (high risk) compared to group A (low risk) in both VSD group [62.5 ± 13 mmHg versus 47 ± 13 mmHg, (p = 0.005) and 9.3 ± 3.3 WU/m 2 versus 3.2 ± 1.3 WU/m 2 , (p = 0.005)] and CAVSD group [62 ± 9 mmHg versus 42 ± 13 mmHg, (p = < 0.001) and 10.3 ± 4 WU/m 2 versus 3.2 ± 1.6 WU/m 2 , (p = 0.001)] respectively. Pulmonary blood flow and pulmonary to systemic blood flow (Qp/Qs) ratio was also significantly higher in low risk group compared to high risk group in both VSD and CAVSD groups ( Table 1) . After inhalation of 100% oxygen the PVRI dropped from 9.4 ± 3.4 WU/m 2 to 3.15 ± 1.4 WU/m 2 in high risk group with VSD ( Fig. 3 , Table 4 ) and from 9.4 ± 3.4 WU/m 2 to 3.15 ± 1.4 WU/m 2 in high risk group with CAVSD ( Fig. 4 , Table 4 ). This drop was mainly because of the increase in pulmonary blood flow. Four patients in CAVSD group who were deemed inoperable had mean PVRI 18 WU/m 2 in room air that dropped to only 7.9 WU/m 2 on 100% oxygen (Tables 2  and 3 ).
Operative and postoperative course
Cardiopulmonary bypass time and cross clamp time were similar in the two groups. Postoperatively all patients were in sinus rhythm. Duration of inotropic support, pulmonary vasodilator therapy, mechanical ventilation, and number of chest tube days were similar in the two groups. Duration of ICU stay was somewhat longer for patients in group B (high risk) but the difference was not statistically significant ( Table 5 ). Nitric oxide inhalation was used for three patients with CAVSD and all of them did well postoperatively. Predicting operability in children with acyanotic congenital heart diseases and severe pulmonary hypertension
Follow up
One patient died within 30 days post-surgery, this was a case of Down syndrome with AVSD who developed sepsis and disseminated intravascular coagulopathy (DIC) in the ICU. Seven more patients died during follow up (range: 1-24 months), making total mortality of 11% (Table 6 ). Three had CAVSD (two from high risk), one case expired 6 month postoperatively and the other two cases expired 24 months postoperatively. The case of death in these three cases was non-cardiac. Four has VSD (three in high risk and one in low risk group). Three of them expired 1.5 month postoperatively. Two of these cases developed pulmonary hypertensive crisis and were treated in ICU by nitric oxide inhalation and hyperventilation, however treatment was not successful. The other 2 cases expired due to non-cardiac causes. Twelve patients were lost to follow up either because of living in other countries or lack of access to medical care.
Discussion
Systemic oxygen saturation (SaO 2 ) in patients having congenital heart diseases with left to right shunts begin to decrease gradually from baseline as they develop increasing PVOD resulting in right to left shunting. 8 We hypothesized that SaO 2 may assist in determining operability in these patients without performing cardiac catheterization. In this series, we reviewed hemodynamic data of patients with VSD and CAV-SD to determine whether SaO 2 measured by pulse oximetry could correctly identify patients who would be declared operable or inoperable based on PVRI measured by cardiac catheterization. Irreversible PVOD is generally not seen below 2 years of age in patients with VSD and below 6 months of age in cases of CAVSD. Majority of such patients generally undergo successful surgical repair earlier in life without preoperative assessment of PVOD. However, the exceptions are not very uncommon, especially in the case of CAVSD, where PVOD generally progresses relatively early, more so in association with Down syndrome. Even very young infants with CAVSD and young children with large VSD occasionally develop severe elevation of PVRI with grade 3 to 4 Heath-Edwards pulmonary vascular changes and therefore, would not be a suitable candidate for surgical repair. On the other hand many older children and some adolescents with same congenital heart diseases show only mild elevation of PVRI and only grade 2 pulmonary vascular changes and qualify for surgery. 3, 8, 13, 14 An essential aspect of the management of patients suspected to have PVOD is to identify those with irreversible pulmonary vascular disease in whom surgical repair is contraindicated. 8, 13, 15 This can be done indirectly by measuring pulmonary vascular resistance during cardiac catheterization. 3, 16, 17 Although a uniform consensus is lacking, in most centers, a patient is considered operable if the PVRI drops to 66 Wood units on vasoreactivity testing with 100% oxygen inhalation with or without nitric oxide, irrespective of PVRI in room air. 14 Out of 84 patients suspected of having significantly elevated PVRI, it was either normal or <6 WU/m 2 in room air in 45 (53.5%) patients. All but one patient in the CAVSD group who were declared operable based on PVRI criterion had SaO 2 of P83% by pulse oximetry and four patients who were declared inoperable had SaO 2 ranging from 75% to 81%. In the VSD group, all patients were declared operable, all but three had SaO 2 P 94%. In a retrospective study David et al. 18 showed that PVRI/SVRI ratio of <0.33 in room air or while breathing 100% oxygen or nitric oxide (NO) is a reliable indicator of operability in patients with elevated PVRI. They also showed that NO inhalation could further allow the identification of operable patients among those with PVRI/SVRI ratio >0.33 while 100% oxygen inhalation would therefore have been incorrectly declared inoperable. In our series PVRI/SVRI ratio could be measured in 84 patients, but only 69 patients were included in the statistical analysis (see Fig. 1 ), in room air (Table 1 ) and in 100% oxygen in 29 patients. Those, who were declared operable had a ratio of <0.33 either in room air (28 patients) or in 100% oxygen (24 patients), (Table 4 ). Four patients with CAVSD, declared inoperable by SaO 2 and PVRI criteria had a ratio P0.45. Thus our data not only confirm their findings but also show that if the SaO 2 is P94% in VSD patients and P83%, their PVRI will be 66 WU/m 2 and PVRI/SVRI will be 60.33 either in room air or in 100% 0xygen. Using receiver operative curve, the sensitivity and specificity of SaO 2 P 83% to identify operable patients based on PVRI criterion were 95% and 100%, respectively and in the CAVSD group and sensitivity and specificity of SaO 2 P 94% to identify operable patients with VSD were 95% and 100%, respectively. Thus using pulse oximetry data we could correctly identify operable patients. We believe that this is an important observation as nearly all operable patients could have been referred for surgical repair without performing cardiac catheterization. Such an approach will not only avoid potential complications of cardiac catheterization, 19, 20 but also allow better time utilization of catheterization laboratory, assisting staff including doctors, and hospital beds in addition of saving the cost of cardiac catheterization, which approximates 2100 US$/patient in our center. Historically, PVRI was routinely measured for all patients with CAVSD, large VSD and patent ductus arteriosus (PDA). Overtime, with increasing expertise, better non-invasive echocardiographic imaging, and improved perioperative care, the value of preoperative hemodynamic assessment was questioned. 15 Zellers et al. 21 recommended to offer complete repair to all infants 61 year of age with CAVSD without hemodynamic evaluation by cardiac catheterization but warned against extrapolating their results and recommendations to older patients because of the concern of pulmonary vascular obstructive disease and poor surgical outcome. Our data suggest that the same can be applied to children up to 10 years of age with both CAVSD and VSD as long as they meet the pulse oximetry criteria of operability. We could correctly classify even a 17 year old with CAVSD and Down's syndrome to be operable by these criteria. This patient is doing very well, off any medication and without residual pulmonary hypertension. Another important observation made in our study was the similar surgical outcome of all operable patients, irrespective of elevation of PVRI with respect to need for inotropic support, mechanical ventilation, hospital stay, and thirty day mortality. Intensive care stay was slightly longer for high risk group but was not statistically different. Thus preoperative knowledge of elevated pulmonary vascular resistance in operable patients did not influence the postoperative management and outcome. These encouraging results in a historically high risk group are the consequence of better understanding of pulmonary hypertension pathophysiology, improved surgical techniques, including myocardial protection during cardiopulmonary bypass, postoperative intensive care, and availability of therapeutic agents like Nitric Oxide, Milrinone, Sildenafil, and inhaled Prostacycline. It needs to be emphasized here that pulse oximetry based criterion is a surrogate for PVRI criterion and therefore, has similar limitations. In this series 5 operated patients continued to have more than half systemic pulmonary hypertension as estimated by velocity of tricuspid regurgitation jet by continuous wave Doppler (Table 7 ). In two cases, protocol for operability was violated as SaO 2 was <83% and PVRI was >6 WU/m 2 (CAVSD patient) and PVRI was >6 WU/m 2 in the case having VSD, and therefore, residual pulmonary hypertension is not surprising. The remaining 3(4%) out of 69 patients who were operated continue to have residual pulmonary arterial hypertension, though improved from baseline. Similar observations have been made previously by others. 3, 14, 15 Outlook of pulmonary hypertension is better than in the past due to availability of pulmonary vasodilator therapy. In our series one patient is receiving low dose Sildenafil and Bosentan, the other two are being closely observed without any pulmonary vasodilator therapy and all are asymptomatic at present. Two patients were lost to follow up but both were asymptomatic at the time of last clinic visit. An additional safeguard that may improve long term outlook of such patients would be to leave a mandatory sufficient fenestration in the atrial septum for all CAVSD patients and in VSD patient older than 2 years of age. Additional stringent criteria suggested by Clapp 3 who did the PVRI in room air only without testing the oxygen reactivity, are probably not a preferable strategy in our opinion. His approach would potentially improve the specificity of identifying truly operable patients but sensitivity will likely become excessively poor and might actually declare operable patients as inoperable.
Conclusion
In children less than 10 years of age, operability indication for patients with VSD and CAVSD, suspected of having significant pulmonary vascular disease may be determined solely by SaO 2 measured by pulse oximetry and without measuring PVRI by cardiac catheterization. Measurement of PVRI is indicated if SaO 2 is <83% in cases of CAVSD and <94% in cases of ventricular septal defect.
Limitations of pulse oximetry
Several factors should be considered with the use of pulse oximetry, since these variables will either alter the accuracy of the readings or may cause harm to the patient. These factors include changes in the strength of the arterial pulse, body movements, dyshemoglobinemias, plasma bilirubin, color interferences, venous pulsations, and several physical factors. Awareness of these variations will help the clinician become more knowledgeable in the use of the pulse oximeter. 22 
